Insider Trading History of Cui Jingrong Jean


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Cui Jingrong Jean since year 2005. The trader's CIK number is 1772259. At the time of the last reporting, Cui Jingrong Jean was the Chief Scientific Officer of Turning Point Therapeutics, Inc. . (stock ticker symbol TPTX). See this page for all insider trading activities at Turning Point Therapeutics, Inc. .


Stock purchases, sales, and option exercises reported by insider Cui Jingrong Jean since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-01-15 TPTX Turning Point Therapeutics, Inc. Sale 11,500 53.34 613,467
2020-01-14 TPTX Turning Point Therapeutics, Inc. Sale 18,500 53.27 985,439
2020-01-10 TPTX Turning Point Therapeutics, Inc. Sale 18,500 56.95 1,053,575
2020-01-13 TPTX Turning Point Therapeutics, Inc. Sale 18,500 53.27 985,495
2019-12-18 TPTX Turning Point Therapeutics, Inc. Sale 18,500 59.10 1,093,350
2019-12-19 TPTX Turning Point Therapeutics, Inc. Sale 18,500 61.09 1,130,072
2019-12-20 TPTX Turning Point Therapeutics, Inc. Sale 11,500 63.35 728,525
2019-12-13 TPTX Turning Point Therapeutics, Inc. Sale 11,500 56.18 646,104
2019-12-16 TPTX Turning Point Therapeutics, Inc. Sale 11,500 58.14 668,575
2019-12-17 TPTX Turning Point Therapeutics, Inc. Sale 18,500 61.55 1,138,638
2019-12-10 TPTX Turning Point Therapeutics, Inc. Sale 11,500 54.70 629,084
2019-12-11 TPTX Turning Point Therapeutics, Inc. Sale 11,500 53.53 615,595
2019-12-12 TPTX Turning Point Therapeutics, Inc. Sale 11,500 54.00 620,965
2019-12-09 TPTX Turning Point Therapeutics, Inc. Sale 11,500 55.60 639,400
2019-12-05 TPTX Turning Point Therapeutics, Inc. Sale 56,110 51.95 2,914,914
2019-12-06 TPTX Turning Point Therapeutics, Inc. Sale 50,890 50.84 2,587,502

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Cui Jingrong Jean (Chief Scientific Officer of Turning Point Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month